Detailed Information on Publication Record
2015
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients
LORENZO-BETANCOR, O., K. OGAKI, A.I. SOTO-ORTOLAZA, C. LABBE, R.L. WALTON et. al.Basic information
Original name
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients
Authors
LORENZO-BETANCOR, O. (840 United States of America), K. OGAKI (840 United States of America), A.I. SOTO-ORTOLAZA (840 United States of America), C. LABBE (840 United States of America), R.L. WALTON (840 United States of America), A.J. STRONGOSKY (840 United States of America), J.A. VAN GERPEN (840 United States of America), R.J. UITTI (840 United States of America), P.J. MCLEAN (840 United States of America), W. SPRINGER (840 United States of America), J. SIUDA (616 Poland), G. OPALA (616 Poland), A. KRYGOWSKA-WAJS (616 Poland), M. BARCIKOWSKA (616 Poland), K. CZYZEWSKI (616 Poland), A. MCCARTHY (372 Ireland), T. LYNCH (372 Ireland), A. PUSCHMANN (752 Sweden), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), Y. SANOTSKY (804 Ukraine), C. VILARINO-GUELL (124 Canada), M.J. FARRER (124 Canada), T.J. FERMAN (840 United States of America), B.F. BOEVE (840 United States of America), R.C. PETERSEN (840 United States of America), J.E. PARISI (840 United States of America), N.R. GRAFF-RADFORD (840 United States of America), D.W. DICKSON (840 United States of America), Z.K. WSZOLEK (840 United States of America) and O.A. ROSS (840 United States of America)
Edition
European Journal of Neurology, Hoboken (USA), Wiley-Blackwell, 2015, 1351-5101
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.956
RIV identification code
RIV/00216224:14740/15:00085056
Organization unit
Central European Institute of Technology
UT WoS
000359863000014
Keywords in English
DNAJC13; genetics; Lewy body disease; Parkinson's disease
Tags
International impact, Reviewed
Změněno: 7/3/2016 15:03, Olga Křížová
Abstract
V originále
BackgroundRecently, a novel mutation in exon 24 of DNAJC13 gene (p.Asn855Ser, rs387907571) has been reported to cause autosomal dominant Parkinson's disease (PD) in a multi-incident Mennonite family. MethodsIn the present study the mutation containing exon of the DNAJC13 gene has been sequenced in a Caucasian series consisting of 1938 patients with clinical PD and 838 with pathologically diagnosed Lewy body disease (LBD). ResultsOur sequence analysis did not identify any coding variants in exon 24 of DNAJC13. Two previously described variants in intron 23 (rs200204728 and rs2369796) were observed. ConclusionOur results indicate that the region surrounding the DNAJC13 p.Asn855Ser substitution is highly conserved and mutations in this exon are not a common cause of PD or LBD among Caucasian populations.